pharmacie et médicaments – Menace sur les remises applicables aux médicaments génériques

This written question concerns the rebates applied to generic medicines in France. It seeks clarification on potential threats to these existing rebate structures. The question impacts pharmaceutical companies, healthcare providers, and potentially patients by affecting the cost and availability of generic drugs.